Study Results Placebo Parkinson

Trophic Factor Study Results: Placebo Effect?

 - 
Results are in from a study of glial cell line-derived neurotrophic factor (GDNF), a “brain fertilizer” that some scientists believe may help protect dopamine cells and improve Parkinson’s symptoms. Many news reports are citing the findings as miraculous, but the response could be due to placebo effect.

Ask the MD: Gene Therapy for Parkinson’s

 - 
Gene therapy is a hot topic in Parkinson’s disease. Researchers are now testing this novel approach in clinical trials of people with mid- to late-stage Parkinson’s. These therapies are intended to treat movement symptoms, lessen levodopa needs and, in turn, limit possible medication complications.
New project AC IMMUNE

New project: AC IMMUNE

 - 
We are happy to announce our support to the upcoming new phase of the pet tracer project of AC IMMUNE, a Swiss biopharmaceutical company.
FAQs on Lewy Body Dementia

Ask the MD: FAQs on Lewy Body Dementia

 - 
What is Lewy body dementia? What is the difference between Lewy body dementia and Alzheimer’s? What is the difference between Parkinson’s disease and Lewy body dementia? Is there a test to diagnose Lewy body dementia? Various questions about Lewy Body Dementia.
Apathy and Parkinson’s Disease

Ask the MD: Apathy and Parkinson’s Disease

 - 
This time of year everyone and everything seems to be focused on exercise as part of a New Year’s resolution. It can be hard for anyone to get and stay motivated, but what if it seems nearly impossible? What if you have no get-up-and-go, or you’re simply not interested? You may be experiencing apathy.
Cognitive Changes in Parkinson's Disease

Ask the MD: Cognitive Changes in Parkinson’s Disease

 - 
Cognitive impairment, disturbance of memory, thinking and/or language abilities, is a non-motor symptom that can be associated with Parkinson’s. Cognitive disturbances can arise at any time in the course of Parkinson’s disease (PD) and vary widely in severity.